This study aims to explore the efficacy and safety of Crizotinb or Standard Chemotherapy in Met exon 14 skipping Advanced Non-small Cell Lung Cancer . We will analysis 100 met exon 14 skipping advanced non-small cell lung cancer who treated with crizotninb or chemotherapy for PFS and OS.
This study aims to explore the efficacy and safety of Crizotinb or Standard Chemotherapy in Met exon 14 skipping Advanced Non-small Cell Lung Cancer